Literature DB >> 16168312

Smallpox.

Sarah D Nafziger1.   

Abstract

Smallpox is a highly infectious disease, which, in 1980, was declared eradicated by the World Health Organization as a result of successful vaccination campaigns. Because of its highly infectious nature and historical 30% mortality rate, the disease has possibly been developed as a biological weapon. Variola, the virus that causes smallpox, is readily transmissible from person to person during the incubation period, before infected individuals show signs of illness. When a victim develops the characteristic rash and viral syndrome associated with smallpox infection, the disease requires complex isolation and possibly quarantine. Diagnosis can be confirmed in a high-containment laboratory. The only effective treatment for smallpox is rapid administration of smallpox vaccine.

Entities:  

Mesh:

Year:  2005        PMID: 16168312     DOI: 10.1016/j.ccc.2005.06.004

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  7 in total

1.  Primary varicella in an immunocompetent adult.

Authors:  Izikson Leonid; Lilly Evelyn
Journal:  J Clin Aesthet Dermatol       Date:  2009-08

2.  Mucosal immunization induces a higher level of lasting neutralizing antibody response in mice by a replication-competent smallpox vaccine: vaccinia Tiantan strain.

Authors:  Bin Lu; Wenbo Yu; Xiaoxing Huang; Haibo Wang; Li Liu; Zhiwei Chen
Journal:  J Biomed Biotechnol       Date:  2011-06-20

3.  Comparison of the safety and pharmacokinetics of ST-246® after i.v. infusion or oral administration in mice, rabbits and monkeys.

Authors:  Yali Chen; Adams Amantana; Shanthakumar R Tyavanagimatt; Daniela Zima; X Steven Yan; Gopi Kasi; Morgan Weeks; Melialani A Stone; William C Weimers; Peter Samuel; Ying Tan; Kevin F Jones; Daniel R Lee; Shirley S Kickner; Bradley M Saville; Martin Lauzon; Alan McIntyre; Kady M Honeychurch; Robert Jordan; Dennis E Hruby; Janet M Leeds
Journal:  PLoS One       Date:  2011-08-15       Impact factor: 3.752

Review 4.  Treatment of neuroterrorism.

Authors:  Katharina M Busl; Thomas P Bleck
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

5.  Voluntary Wheel Running Does Not Alter Mortality to or Immunogenicity of Vaccinia Virus in Mice: A Pilot Study.

Authors:  Brandt D Pence; Melissa R Ryerson; Ariana G Bravo Cruz; Jeffrey A Woods; Joanna L Shisler
Journal:  Front Physiol       Date:  2018-01-05       Impact factor: 4.566

6.  Political will and international collaborative frameworks in infectious diseases.

Authors:  R A Stein
Journal:  Int J Clin Pract       Date:  2015-01       Impact factor: 2.503

7.  One time intranasal vaccination with a modified vaccinia Tiantan strain MVTT(ZCI) protects animals against pathogenic viral challenge.

Authors:  Wenbo Yu; Qing Fang; Weijun Zhu; Haibo Wang; Po Tien; Linqi Zhang; Zhiwei Chen
Journal:  Vaccine       Date:  2009-12-30       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.